This is a news story, published by ScienceDaily, that relates primarily to Rutgers Health news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from ScienceDaily, you can click here:
more news from ScienceDailyOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
generalized lipodystrophy. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Congenital generalized lipodystrophy news, lipodystrophy news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
supplemental insulin injectionsScienceDaily
•Health
Health
75% Informative
A diabetes drug may beat costly daily hormone shots for patients with a rare genetic condition, Rutgers Health study says.
Treatment for Congenital generalized lipodystrophy affects only a few thousand people worldwide.
With no fat tissue for proper storage, fat accumulates in organs such as the liver, leading to insulin resistance and diabetes.
VR Score
84
Informative language
90
Neutral language
32
Article tone
formal
Language
English
Language complexity
67
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links
